JOINT FORCE QUARTERLY 103
Read more →
PRISM Vol. 9, No. 3
Joint Force Quarterly 103 | Oct. 14, 2021
Christopher D. Holmes
How the senior enlisted advisor to the Chairman (SEAC) position developed mirrors how other such senior enlisted advisor positions began and reflects the evolution of jointness.
PRISM Vol. 9, No. 3 | Nov. 18, 2021
Justin Bernier
This article discusses China’s strategy for achieving its global ambitions and how it is driven as much by bankers and bribes as bombs and bullets. It looks into how the Chinese Communist Party (CCP) continues to take every step imaginable to appropriate dual-use technologies—those with both civil and military applications—from the United States and its allies, while attracting billions of dollars in Western capital used to finance a modernization program for the People’s Liberation Army (PLA).
Michael Clark, Erik Jorgensen, and Gordon M. Schriver
Alliance leaders should more heavily weigh insights from their own military doctrine when deliberating if and how to embark on another humanitarian intervention using airpower without a conventional ground force. At a minimum, such consideration should give NATO leaders a better sense of what is realistically possible with airpower. With this better sense, they should be able to make more effective decisions on, if, and how to use the military instrument to achieve humanitarian objectives if airpower is the most robust military means available to them.
Seth Kaplan
In the United States’ effort to outcompete China, Russia, and other rivals, its ideas are likely to play a defining role in determining the strength of alliances and the vulnerability of foes. The more its ideas have an inherent appeal based on their universality—transcending culture and context—the more likely the United States will be able to leverage them to forge a coalition that can withstand geopolitical threats and apply pressure for reform in places like China.
Drew Thompson
Lt Col T. Justin Bronder, USAF
NDU Press
Douglas Farah and Marianne Richardson
Bryce Loidolt